Matinas BioPharma Holdings, Inc. (NYSE:MTNB) Q3 2022 Results Conference Call November 2, 2022 4:30 PM ET Company Participants Ankit Bhargava - Investor Relations Jerry Jabbour - Chief Executive Officer Terry Matkovits - Chief Development Officer Terry Ferguson - Chief Medical Officer Keith Kucinski - Chief Financial Officer Thomas Hoover - Chief Business Officer Conference Call Participants Greg Fraser - Truist Robert Hazlett - BTIG Sahil Kazmi - B. Riley Securities Operator Welcome to the Matinas BioPharma ...

MATINAS BIOPHARMA Corporate Presentation September 2022 Forward Looking Statements This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including those relating to the Company's product development, clinical and regulatory timelines, market opportunity, cash flow and other statements that are predictive in nature, that depend upon or refer to future events or conditions. All statements other than statements of historical fact are ...

Matinas BioPharma Holdings, Inc. (NYSE:MTNB) Q2 2022 Earnings Conference Call August 11, 2022 8:30 AM ET Company Participants Peter Vozzo - Investor Relations Representative Jerry Jabbour - Chief Executive Officer Dr. Terry Matkovits - Chief Development Officer Keith Kucinski - Chief Financial Officer Dr. Raphael Mannino - Chief Scientific Officer Dr. Terry Ferguson - Chief Medical Officer Thomas Hoover - Chief Business Officer Conference Call Participants Bert Hazlett - BTIG Operator Hello. And welcome to ...

MATINAS 1 BIOPHARMA Corporate Presentation May 2022 Forward-Looking Statement This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including those relating to the Company's product development, clinical and regulatory timelines, market opportunity, cash flow and other statements that are predictive in nature, that depend upon or refer to future events or conditions. All statements other than statements of historical fact are stat ...

Matinas BioPharma Holdings Inc. (NYSE:MTNB) Q1 2022 Earnings Conference Call May 12, 2022 8:30 AM ET Company Participants Jerome Jabbour - Chief Executive Officer Theresa Matkovits - Chief Development Officer Terry Ferguson - Chief Medical Officer Keith Kucinski - Chief Financial Officer Peter Vozzo - Investor Relations Conference Call Participants Bert Hazlett - BTIG Operator Welcome to the Matinas BioPharma First Quarter 2022 Results Conference Call. At this time, all participants are in a listen-only m ...

Matinas BioPharma Holdings, Inc. (NYSE:MTNB) Q4 2021 Earnings Conference Call March 8, 2022 8:30 AM ET Company Participants Peter Vozzo - Investor Relations Jerome Jabbour - Chief Executive Officer Keith Kucinski - Chief Financial Officer Terry Ferguson - Chief Medical Officer Conference Call Participants Robert Hazlett - BTIG Greg Fraser - Truist Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to ...

Matinas BioPharma Holdings, Inc. (NYSE:MTNB) Q3 2021 Earnings Conference Call November 8, 2021 8:30 AM ET Company Participants Peter Vozzo - Investor Relations Jerome Jabbour - Chief Executive Officer Keith Kucinski - Chief Financial Officer Terry Ferguson - Chief Medical Officer Terry Matkovits - Chief Development Officer Raphael Mannino - Chief Scientific Officer Conference Call Participants Robert Hazlett - BTIG Greg Fraser - Truist Operator Greetings and welcome to Matinas BioPharma's Third Quarter 2021 ...

Matinas BioPharma Holdings, Inc. (NYSE:MTNB) Q2 2021 Results Conference Call August 10, 2021 8:00 AM ET Company Participants Jerome Jabbour ??? Chief Executive Officer Peter Vozzo ??? Investor Relations Keith Kucinski ??? Chief Financial Officer Terry Ferguson ??? Chief Medical Officer Terry Matkovits ??? Chief Development Officer Raphael Mannino ??? Chief Scientific Officer Unidentified Company Representative ??? Company Participant Conference Call Participants Robert Hazlett ??? BTIG Greg Fraser ??? Truis ...

Matinas BioPharma Holdings, Inc. (NYSE:MTNB) Q1 2021 Earnings Conference Call May 10, 2021 8:00 AM ET Company Participants Peter Vozzo - Investor Relations Jerome Jabbour - Chief Executive Officer Keith Kucinski - Chief Financial Officer Conference Call Participants Robert Hazlett - BTIG Yasmeen Rahimi - Piper Sandler Gregory Fraser - Truist Securities Operator Hello, and welcome to the Matinas BioPharma's Q1 2021 Results Conference Call and Webcast. At this time, all participants are in a listen-only mode. ...

MATINAS 1 BIOPHARMA Corporate Presentation April/May 2021 Forward-Looking Statement This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including those relating to the Company's product development, clinical and regulatory timelines, market opportunity, cash flow and other statements that are predictive in nature, that depend upon or refer to future events or conditions. All statements other than statements of historical fact ar ...